Literature DB >> 16556635

Expression and potential function of cathelicidin antimicrobial peptides in dermatophytosis and tinea versicolor.

Belén López-García1, Phillip H A Lee, Richard L Gallo.   

Abstract

OBJECTIVES: This study was designed to characterize the role of the human cathelicidin LL-37 in fungal skin infections such as dermatophytosis and tinea versicolor.
METHODS: The in vitro antimicrobial activity of synthetic antimicrobial peptides including the human cathelicidin LL-37 against Malassezia furfur and several dermatophytes was determined. Immunostaining was performed to determine expression of cathelicidin in skin biopsies from patients with tinea pedis, tinea corporis and tinea versicolor. Cathelicidin peptide expression was evaluated by western blotting and mRNA expression was studied in keratinocytes exposed to M. furfur or Trichophyton rubrum.
RESULTS: LL-37 inhibits the growth of fungi with an MIC of 20-30 microM for M. furfur and 12.5 microM for Trichophyton mentagrophytes and T. rubrum. LL-37 also shows fungicidal activity with a minimum fungicidal concentration (MFC) of 12.5 and 25 microM for T. mentagrophytes and T. rubrum, respectively. An increase in cathelicidin expression was observed in human skin tissue infected with fungi compared with healthy skin. Western blotting of skin scrapings demonstrated that human cathelicidin is processed from its precursor into an active peptide in both healthy and infected plantar skin.
CONCLUSIONS: These findings support a hypothesis that antimicrobial peptides such as cathelicidins can play a role in skin defence against dermatophytes and M. furfur.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16556635     DOI: 10.1093/jac/dkl078

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  13 in total

Review 1.  Are Th17 Cells Playing a Role in Immunity to Dermatophytosis?

Authors:  Marie-Pierre Heinen; Ludivine Cambier; Laurence Fievez; Bernard Mignon
Journal:  Mycopathologia       Date:  2016-11-23       Impact factor: 2.574

Review 2.  [Psoriasis and the microbiome].

Authors:  M Witte; D Thaçi
Journal:  Hautarzt       Date:  2019-06       Impact factor: 0.751

3.  Innate immunity and the role of the antimicrobial peptide cathelicidin in inflammatory skin disease.

Authors:  Keith D Roby; Anna Di Nardo
Journal:  Drug Discov Today Dis Mech       Date:  2013-12-01

4.  Autosomal Recessive Congenital Ichthyosis in American Bulldogs Is Associated With NIPAL4 (ICHTHYIN) Deficiency.

Authors:  E A Mauldin; P Wang; E Evans; C A Cantner; J D Ferracone; K M Credille; M L Casal
Journal:  Vet Pathol       Date:  2014-10-16       Impact factor: 2.221

Review 5.  Alternative approaches to antifungal therapies.

Authors:  Tarun Mehra; Martin Köberle; Christina Braunsdorf; Daniela Mailänder-Sanchez; Claudia Borelli; Martin Schaller
Journal:  Exp Dermatol       Date:  2012-10       Impact factor: 3.960

6.  Antifungal activities of peptides derived from domain 5 of high-molecular-weight kininogen.

Authors:  Andreas Sonesson; Emma Andersson Nordahl; Martin Malmsten; Artur Schmidtchen
Journal:  Int J Pept       Date:  2011-09-14

7.  Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease.

Authors:  Markus Reinholz; Thomas Ruzicka; Jürgen Schauber
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444

Review 8.  Short antimicrobial peptides as cosmetic ingredients to deter dermatological pathogens.

Authors:  Mohammad Rahnamaeian; Andreas Vilcinskas
Journal:  Appl Microbiol Biotechnol       Date:  2015-08-26       Impact factor: 4.813

Review 9.  Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds.

Authors:  Małgorzata Bondaryk; Monika Staniszewska; Paulina Zielińska; Zofia Urbańczyk-Lipkowska
Journal:  J Fungi (Basel)       Date:  2017-08-26

Review 10.  Psoriasis and Microbiota: A Systematic Review.

Authors:  Farida Benhadou; Dillon Mintoff; Benjamin Schnebert; Hok Bing Thio
Journal:  Diseases       Date:  2018-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.